Replies to post #109 on Portola Phramaceuticals (PTLA)

[DewDiligence]

Each case has to be considered on its own merits. I'm not sufficiently familiar with the NBIX application to add any insight about that situation, but I've previously posted my reasons for being bearish about Betrixaban.